Prostaglandin E-major urinary metabolite (PGE-MUM) is a valuable biomarker reflecting the cytokine profile. We encountered a case of a 14-year-old boy with pan-colitis-type ulcerative colitis who was unresponsive to steroids and infliximab. The patient's clinical symptoms gradually deteriorated and surgical treatment was strongly considered because anti-inflammatory therapy was unlikely to be effective. PGE-MUM levels were markedly elevated, indicating a T-helper 17 (Th17)-like cytokine profile. Because an antibody against interleukin 23 (IL-23) was presumed to be effective, the patient was treated with mirikizumab, after which he achieved remission. In the present case, measurement of PGE-MUM levels was useful in selecting anti-cytokine treatments for severe ulcerative colitis.
Nat Immunol. 2019 Aug;20(8):970-979
[PMID:
31235952]
J Eur Acad Dermatol Venereol. 2020 Dec;34(12):2830-2838
[PMID:
32320088]
Gastroenterology. 2007 Aug;133(2):423-32
[PMID:
17681163]
J Crohns Colitis. 2021 Oct 7;15(10):1605-1620
[PMID:
34160593]
Int Immunol. 2019 Aug 23;31(9):597-606
[PMID:
30926983]
N Engl J Med. 1987 Dec 24;317(26):1625-9
[PMID:
3317057]
Autoimmun Rev. 2022 Mar;21(3):103017
[PMID:
34902606]
Digestion. 2016;93(1):32-9
[PMID:
26788915]
Nature. 2003 Feb 13;421(6924):744-8
[PMID:
12610626]
J Pediatr Gastroenterol Nutr. 2017 Jun;64(6):955-961
[PMID:
27906804]
N Engl J Med. 2023 Jun 29;388(26):2444-2455
[PMID:
37379135]
Crohns Colitis 360. 2024 Jan 06;6(1):otae001
[PMID:
38313767]
